P5CR1 protein expression and the effect of gene-silencing on lung adenocarcinoma.

Cisplatin resistance Invasion Lung adenocarcinoma Migration PYCR1 gene Proliferation

Journal

PeerJ
ISSN: 2167-8359
Titre abrégé: PeerJ
Pays: United States
ID NLM: 101603425

Informations de publication

Date de publication:
2019
Historique:
received: 08 01 2019
accepted: 09 04 2019
entrez: 31 5 2019
pubmed: 31 5 2019
medline: 31 5 2019
Statut: epublish

Résumé

The present study aimed to investigate the expression of pyrroline-5-carboxylate reductase 1 (P5CR1) protein in lung adenocarcinoma and paracancerous tissues and to explore the effect of silencing the encoding gene

Identifiants

pubmed: 31143549
doi: 10.7717/peerj.6934
pii: 6934
pmc: PMC6524628
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e6934

Déclaration de conflit d'intérêts

The authors declare that they have no competing interests.

Références

Carcinogenesis. 2005 Aug;26(8):1335-42
pubmed: 15817612
Genes Dev. 2007 May 1;21(9):1025-30
pubmed: 17437991
Amino Acids. 2008 Nov;35(4):651-2
pubmed: 18504525
Nature. 2009 Apr 9;458(7239):762-5
pubmed: 19219026
Nat Genet. 2009 Sep;41(9):1016-21
pubmed: 19648921
Curr Pharm Des. 2012;18(10):1319-30
pubmed: 22360558
Front Oncol. 2012 Jun 21;2:60
pubmed: 22737668
PLoS One. 2012;7(9):e45190
pubmed: 23024808
J Biol Chem. 2013 Feb 1;288(5):3500-11
pubmed: 23239881
Epigenetics. 2013 Mar;8(3):231-6
pubmed: 23422013
Cancer J. 2013 May-Jun;19(3):200-7
pubmed: 23708066
Nat Commun. 2014;5:3128
pubmed: 24451681
Lung Cancer. 2014 Apr;84(1):13-22
pubmed: 24524818
Adv Cancer Res. 2015;125:71-96
pubmed: 25640267
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Autophagy. 2015 Apr 3;11(4):725-6
pubmed: 25905679
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
J Thorac Oncol. 2016 Oct;11(10):e121-3
pubmed: 27257132
Med Oncol. 2017 Feb;34(2):27
pubmed: 28078560
Carcinogenesis. 2017 May 1;38(5):519-531
pubmed: 28379297
Cancer Metastasis Rev. 2017 Sep;36(3):503-514
pubmed: 28819926
Oncol Lett. 2018 Jan;15(1):731-740
pubmed: 29403556
Cancer Manag Res. 2018 Nov 27;10:6399-6407
pubmed: 30568501
Biomed Pharmacother. 2019 Mar;111:588-595
pubmed: 30605882

Auteurs

Yang She (Y)

Clinical Laboratory, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou City, Hainan Province, China.

Aiyou Mao (A)

Clinical Laboratory, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou City, Hainan Province, China.

Feng Li (F)

Clinical Laboratory, Hainan Provincial People's Hospital, Haikou City, Hainan Province, China.

Xiaobin Wei (X)

Clinical Laboratory, Central South University Xiangya School of Medicine Affiliated Haikou Hospital, Haikou City, Hainan Province, China.

Classifications MeSH